We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Improved Medical Implants Could Influence Immune System to Help Instead of Harming the Body

By HospiMedica International staff writers
Posted on 25 Oct 2023
Print article
Image: New insight into immune response forges a path toward improved medical implants (Photo courtesy of NIH Medical Arts)
Image: New insight into immune response forges a path toward improved medical implants (Photo courtesy of NIH Medical Arts)

Medical implants like pacemakers, breast implants, or knee replacements can sometimes create unfavorable immune reactions that harm both the implant and the nearby tissue. The standard clinical approach to handle this has been to use immunosuppressive drugs, which don't always work effectively and carry significant risks. When these immune-related complications arise, patients often require additional surgeries to replace or remove the compromised implants. Though scientists don't yet fully understand why these immune responses occur, new research is shedding light on some crucial factors.

Natural implants, such as tissue grafts, have been found to guide the immune system in a more positive direction by encouraging healing processes. While natural materials can't be used for all medical applications, the lessons they provide can be valuable for other types of implants. Researchers at the National Institute of Biomedical Imaging and Bioengineering (NIBIB, Bethesda, MD, USA) studied how the immune system reacts differently to two materials implanted in mice. Their findings help lay the groundwork for designing medical devices that could work in harmony with the immune system, rather than against it.

To explore the differences in immune responses to various materials, scientists removed muscle from the legs of mice and filled the gaps with two different materials. One was decellularized small intestinal submucosa, which is pig tissue stripped of its cells, leaving mostly collagen. This material has been shown to encourage healing processes. The other was polyethylene, a plastic often used in orthopedic implants, known to cause long-term inflammation and scarring. A third group of mice with muscle removed was left untreated as a control group.

By employing flow cytometry, the researchers identified and counted various cell types in the tissue taken from the mice. As anticipated, samples with the submucosa showed a greater tendency towards anti-inflammatory reactions and healing compared to the polyethylene samples. Notably, one specific cell type, called cDC1s and belonging to the dendritic cell class, was much more prevalent in the submucosa samples. Dendritic cells help the immune system distinguish between harmful and harmless entities. When these dendritic cells were genetically blocked in mice, both inflammation and scarring increased, irrespective of the implanted material.

Additional experiments revealed that a type of immune cell called natural killer cells were signaling for the recruitment of this specific dendritic cell subtype, a process commonly seen in tumor-related immune responses. The researchers believe that molecular signals likely present in pig submucosa but not in polyethylene could be the reason for the different immune reactions observed. Moving forward, the research team aims to pinpoint the specific proteins and molecules that trigger these healing responses. Their goal is to incorporate these molecules into existing or new medical devices to make them more compatible with the body's immune system, thus increasing their safety and longevity.

“Implants frequently cause pain and, in many cases, need to be removed within a few years. We’re looking to eventually eliminate that grief by extending the lifespan of implanted medical devices to the lifespan of patients,” said Kaitlyn Sadtler, Ph.D., Earl Stadtman Tenure-Track Investigator and chief of the Section on Immunoengineering at NIBIB. “If we could tease out what aspect of these different materials causes certain immune responses, we would have more control in designing materials and devices that encourage the responses we want.”

Related Links:
NIBIB 

New
Gold Member
X-Ray QA Meter
T3 AD Pro
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Radiology Software
DxWorks
New
Gold Member
X-Ray QA Meter
T3 RG Pro

Print article

Channels

Critical Care

view channel
Image: Artificial intelligence-derived intracranial pressure monitors vital information noninvasively (Photo courtesy of Icahn Mount Sinai)

AI-Driven Tool to Revolutionize Brain Pressure Monitoring in Intensive Care Patients

Intracranial hypertension, characterized by increased pressure within the brain, can lead to severe consequences such as strokes and hemorrhages. Traditionally, monitoring this condition requires invasive... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
The Atellica VTLi Patient-side Immunoassay Analyzer, a high-sensitivity troponin I test at the bedside, delivers accurate results in just 8 minutes (Photo courtesy of Siemens Healthineers)

New 8-Minute Blood Test to Diagnose or Rule Out Heart Attack Shortens ED Stay

Emergency department overcrowding is a significant global issue that leads to increased mortality and morbidity, with chest pain being one of the most common reasons for hospital admissions.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.